— Know what they know.
Not Investment Advice

USNA NYSE

USANA Health Sciences, Inc.
1W: +3.4% 1M: -4.9% 3M: -14.3% YTD: -4.5% 1Y: -38.2% 3Y: -70.9% 5Y: -81.4%
$18.74
+0.18 (+0.97%)
 
Weekly Expected Move ±7.3%
$15 $17 $18 $19 $20
NYSE · Consumer Defensive · Packaged Foods · Alpha Radar Neutral · Power 50 · $346.0M mcap · 10M float · 1.35% daily turnover · Short 74% of daily vol

Cash Flow Trends

Operating Cash Flow
$22M -63.4% ▼
5Y CAGR: -32.6%
Capital Expenditures
$14M -37.2% ▼
5Y CAGR: -1.7%
Free Cash Flow
$9M -83.3% ▼
5Y CAGR: -43.3%
Dividends Paid
$0 +0.0% ▲
Buybacks
$28M -191.3% ▼
Net Change in Cash
-$23M +84.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$117M$69M$64M$42M$11M
Depreciation & Amort.$22M$21M$20M$22M$33M
Stock-Based Comp.$14M$13M$15M$15M$14M
Change in Working Capital-$29M$771K-$28M-$13M-$43M
Other Non-Cash Items$61K$6M$3M$2M$15M
Operating Cash Flow$121M$104M$71M$61M$22M
— Investing Activities —
Capital Expenditures-$13M-$10M-$14M-$10M-$14M
Acquisitions (Net)-$2M-$7M$0-$203M$0
Investment Purchases-$2M$0-$1M-$870K$0
Investment Sales$2M$5M$4M$1M$0
Other Investing$131K$7K$15K$64K$4M
Investing Cash Flow-$14M-$12M-$12M-$213M-$10M
— Financing Activities —
Net Debt Issuance$0$0$792K$22M-$9M
Stock Repurchased-$178M-$25M-$12M-$9M-$28M
Dividends Paid$0$0$0$0$0
Other Financing-$4M-$5M-$3M-$3M-$4M
Financing Cash Flow-$181M-$30M-$14M$10M-$41M
Net Change in Cash-$72M$48M$42M-$149M-$23M
Cash End of Period$244M$291M$333M$185M$161M
Free Cash Flow$108M$94M$56M$51M$9M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms